The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation
Open accessAbstract
Hydrogen sulfide (H2S) has been shown to have powerful antioxidative and anti-inflammatory properties that can regulate multiple cardiovascular functions. However, its precise role in diabetes-accelerated atherosclerosis remains unclear. We report here that H2S reduced aortic atherosclerotic plaque formation with reduction in superoxide (O2−) generation and the adhesion molecules in streptozotocin (STZ)-induced LDLr−/− mice but not in LDLr−/−Nrf2−/− mice. In vitro, H2S inhibited foam cell formation, decreased O2− generation, and increased nuclear factor erythroid 2–related factor 2 (Nrf2) nuclear translocation and consequently heme oxygenase 1 (HO-1) expression upregulation in high glucose (HG) plus oxidized LDL (ox-LDL)–treated primary peritoneal macrophages from wild-type but not Nrf2−/− mice. H2S also decreased O2− and adhesion molecule levels and increased Nrf2 nuclear translocation and HO-1 expression, which were suppressed by Nrf2 knockdown in HG/ox-LDL–treated endothelial cells. H2S increased S-sulfhydration of Keap1, induced Nrf2 dissociation from Keap1, enhanced Nrf2 nuclear translocation, and inhibited O2− generation, which were abrogated after Keap1 mutated at Cys151, but not Cys273, in endothelial cells. Collectively, H2S attenuates diabetes-accelerated atherosclerosis, which may be related to inhibition of oxidative stress via Keap1 sulfhydrylation at Cys151 to activate Nrf2 signaling. This may provide a novel therapeutic target to prevent atherosclerosis in the context of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
H 2 S Signals Through Protein S-Sulfhydration
Mustafa, A. K., Gadalla, M. M., Sen, N., Kim, S., Mu, W., Gazi, S. K., Barrow, R. K., Yang, G., Wang, R., & Snyder, S. H. (2009) · Science Signaling · doi:10.1126/scisignal.2000464 · Cited by 1,231
Niture, S. K., Khatri, R., & Jaiswal, A. K. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.008 · Cited by 868
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
Calvert, J. W., Jha, S., Gundewar, S., Elrod, J. W., Ramachandran, A., Pattillo, C. B., Kevil, C. G., & Lefer, D. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.199919 · Cited by 723
Yang, G., Zhao, K., Ju, Y., Mani, S., Cao, Q., Puukila, S., Khaper, N., Wu, L., & Wang, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4645 · Cited by 563
Decreased Endogenous Production of Hydrogen Sulfide Accelerates Atherosclerosis
Mani, S., Li, H., Untereiner, A., Wu, L., Yang, G., Austin, R. C., Dickhout, J. G., Lhoták, Š., Meng, Q. H., & Wang, R. (2013) · Circulation · doi:10.1161/circulationaha.113.002208 · Cited by 377
Wang, Y., Zhao, X., Jin, H., Wei, H., Li, W., Bu, D., Tang, X., Ren, Y., Tang, C., & Du, J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179333 · Cited by 307
Self-citationZhang, D. D., Lo, S.-C., Sun, Z., Habib, G. M., Lieberman, M. W., & Hannink, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501279200 · Cited by 298
Suzuki, K., Olah, G., Modis, K., Coletta, C., Kulp, G., Gerö, D., Szoleczky, P., Chang, T., Zhou, Z., Wu, L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105121108 · Cited by 287
Eckel, R. H., Wassef, M., Chait, A., Sobel, B., Barrett, E., King, G., Lopes-Virella, M., Reusch, J., Ruderman, N., Steiner, G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000013954.65303.c5 · Cited by 199
Liu, Z., Han, Y., Li, L., Lu, H., Meng, G., Li, X., Shirhan, M., Peh, M. T., Xie, L., Zhou, S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12246 · Cited by 181
Self-citationBarajas, B., Che, N., Yin, F., Rowshanrad, A., Orozco, L. D., Gong, K. W., Wang, X., Castellani, L. W., Reue, K., Lusis, A. J., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.210906 · Cited by 169
Self-citationPeake, B. F., Nicholson, C. K., Lambert, J. P., Hood, R. L., Amin, H., Amin, S., & Calvert, J. W. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00796.2012 · Cited by 166
Ding, Y., Zhang, B., Zhou, K., Chen, M., Wang, M., Jia, Y., Song, Y., Li, Y., & Wen, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.045 · Cited by 162
Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitro
Ferro, A., Queen, L. R., Priest, R. M., Xu, B., Ritter, J. M., Poston, L., & Ward, J. P. T. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702512 · Cited by 161
Self-citationHydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model
Zhou, X., Feng, Y. Y., Zhan, Z., & Chen, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596593 · Cited by 148
Chemistry of the Cysteine Sensors in Kelch-Like ECH-Associated Protein 1
Holland, R., & Fishbein, J. C. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3273 · Cited by 115
Tan, S. M., Sharma, A., Stefanovic, N., Yuen, D. Y. C., Karagiannis, T. C., Meyer, C. J., Ward, K. W., Cooper, M. E., & de Haan, J. B. (2014) · Diabetes · doi:10.2337/db13-1743 · Cited by 113
The absence of macrophage Nrf2 promotes early atherogenesis
Ruotsalainen, A.-K., Inkala, M., Partanen, M. E., Lappalainen, J. P., Kansanen, E., Mäkinen, P. I., Heinonen, S. E., Laitinen, H. M., Heikkilä, J., Vatanen, T., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt008 · Cited by 109
Wang, X., Wang, F., You, S., Cao, Y., Cao, L.-D., Han, Q., Liu, C., & Hu, L. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.010 · Cited by 109
Self-citationReduction in ABCG1 in Type 2 Diabetic Mice Increases Macrophage Foam Cell Formation
Mauldin, J., Srinivasan, S. R., Mulya, A., Gebre, A. K., Parks, J. S., Daugherty, A., & Hedrick, C. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510952200 · Cited by 100
Keap1 Cysteine 288 as a Potential Target for Diallyl Trisulfide-Induced Nrf2 Activation
Kim, S., Lee, H.-G., Park, S., Kundu, J. K., Keum, Y., Cha, Y., Na, H., & Surh, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085984 · Cited by 95
Collins, A. R., Gupte, A. A., Ji, R., Ramirez, M., Minze, L. J., Liu, J. Z., Arredondo, M., Ren, Y., Deng, T., Wang, J., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300345 · Cited by 92
Treatment with hydrogen sulfide alleviates streptozotocin‐induced diabetic retinopathy in rats
Si, Y., Wang, J., Guan, J., Zhou, L., Sheng, Y., & Zhao, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12163 · Cited by 90
Manna, P., & Jain, S. K. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24578 · Cited by 86
Use of the “Tag-Switch” Method for the Detection of Protein S-Sulfhydration
Park, C., Mačinković, I., Filipović, M. R., & Xian, M. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.11.033 · Cited by 51
Cheng, W., Wang, P., Wang, T., Zhang, Y., Cheng, D., Li, H., & Ji, Y. H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12991 · Cited by 47
Self-citationZhou, X., An, G., & Chen, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12254 · Cited by 39
Ramprasath, T., & Selvam, G. S. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990154 · Cited by 35
Xu, X., Luo, P., Wang, Y., Cui, Y., & Miao, L. (2013) · Journal of International Medical Research · doi:10.1177/0300060513477004 · Cited by 30
Self-citationXie, L., Liu, Z., Lu, H., Zhang, W., Mi, Q., Li, X., Tang, Y., Chen, Q., Ferro, A., & Ji, Y. H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01607.x · Cited by 25
Self-citationMi, Q., Chen, N., Shaifta, Y., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.017 · Cited by 17
Cited by
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
Sun, H.-J., Wu, Z.-Y., Nie, X.-W., & Bian, J.-S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01568 · Cited by 554
Pedre, B., Barayeu, U., Ezeriņa, D., & Dick, T. P. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107916 · Cited by 470
Szabo, C., & Papapetropoulos, A. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014050 · Cited by 423
Metadata
- Authors
- Xie, L., Gu, Y., Wen, M., Zhao, S., Wang, W., Ma, Y., Meng, G., Han, Y., Wang, Y., Liu, G., Moore, P. K., Wang, X., Wang, H., Zhang, Z., Yu, Y., Ferro, A., Huang, Z., & Ji, Y.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-06-22
- Volume
- 65
- Issue
- 10
- Pages
- 3171-3184
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2460464816
- Cited by
- 336
- References
- 34
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.